comparemela.com

Page 15 - Eva Kalias News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Santhera Updates on Ongoing NDA Submission for Vamorolone

Santhera Updates on Ongoing NDA Submission for Vamorolone
dkoding.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dkoding.in Daily Mail and Mail on Sunday newspapers.

Switzerland generalUnited statesUnited kingdomEva kaliasLife science allianceSanthera pharmaceuticalsHead investor relations communicationsEuropean medicines agencyChiesi groupDrug administrationSanthera pharmaceuticals holdingOrphan drugFast trackRare pediatric diseasePromising innovative medicineProc natl acad sci united states

Santhera Nominates Thomas Meier, PhD, to Succeed Elmar Schnee as Chairman of the Board

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Switzerland generalUnited statesElmar schneeEva kaliasThomas meierSanthera pharmaceuticalsHead investor relations communicationsChiesi groupCompensation committee of santheraCompensation committeeSanthera pharmaceuticals holdingBoard elmar schneeAnnual general meetingAnnual generalNorth americaHead investor relations

Investegate |Santhera Pharmaceuticals Holdi Announcements | Santhera Pharmaceuticals Holdi: Santhera Nominates Thomas Meier, PhD, to Succeed Elmar Schnee as Chairman of the Board

Investegate announcements from Santhera Pharmaceuticals Holdi, Santhera Nominates Thomas Meier, PhD, to Succeed Elmar Schnee as Chairman of the Board

Switzerland generalUnited statesElmar schneeEva kaliasThomas meierSanthera pharmaceuticalsHead investor relations communicationsChiesi groupCompensation committee of santheraCompensation committeeSanthera pharmaceuticals holdingSanthera nominates thomas meierSucceed elmar schneeBoard elmar schneeAnnual general meetingAnnual general

Santhera Pharmaceuticals Holding AG: Santhera Nominates Thomas Meier, PhD, to Succeed Elmar Schnee as Chairman of the Board

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, June 27, 2022 Santhera Pharmaceuticals (SIX: SANN) announces that Chairman of the Board Elmar Schnee will not stand for re-election

Switzerland generalUnited statesElmar schneeEva kaliasThomas meierSanthera pharmaceuticalsHead investor relations communicationsChiesi groupCompensation committee of santheraCompensation committeeSanthera pharmaceuticals holdingBoard elmar schneeAnnual general meetingNorth americaHead investor relations

Santhera Pharmaceuticals Holding AG: Santhera Reports 2021 Annual Results

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held today at 14:30 CEST, 13:30 BST, 08:30 EDT. Details are at the end of this statement. Revenue from contracts with customers

Switzerland generalUnited statesShabir hashamAndrew smithEva kaliasDario eklundSanthera pharmaceuticalsChiesi groupHighbridge capital managementSanthera pharmaceuticals holdingPuldysa phaseSperogenix therapeuticsGreater chinaAnnual reportSanthera annual reportGeneral meeting

vimarsana © 2020. All Rights Reserved.